ZA896463B - Thrombus control agent - Google Patents

Thrombus control agent

Info

Publication number
ZA896463B
ZA896463B ZA896463A ZA896463A ZA896463B ZA 896463 B ZA896463 B ZA 896463B ZA 896463 A ZA896463 A ZA 896463A ZA 896463 A ZA896463 A ZA 896463A ZA 896463 B ZA896463 B ZA 896463B
Authority
ZA
South Africa
Prior art keywords
human
csf
control agent
thrombus control
thrombus
Prior art date
Application number
ZA896463A
Other languages
English (en)
Inventor
Koichiro Tsuji
Tsuji Koichiro
Masayoshi Ono
Ono Masayoshi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA896463B publication Critical patent/ZA896463B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Networks Using Active Elements (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA896463A 1988-08-24 1989-08-24 Thrombus control agent ZA896463B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21037688 1988-08-24

Publications (1)

Publication Number Publication Date
ZA896463B true ZA896463B (en) 1990-05-30

Family

ID=16588321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896463A ZA896463B (en) 1988-08-24 1989-08-24 Thrombus control agent

Country Status (8)

Country Link
US (1) US5202117A (fr)
EP (1) EP0355811B1 (fr)
KR (1) KR950003492B1 (fr)
AT (1) ATE97813T1 (fr)
CA (1) CA1339071C (fr)
DE (1) DE68911061T2 (fr)
IL (1) IL91423A (fr)
ZA (1) ZA896463B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
FR2693907B1 (fr) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
US5879794A (en) * 1994-08-25 1999-03-09 W. L. Gore & Associates, Inc. Adhesive-filler film composite
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO1998020528A1 (fr) 1996-11-08 1998-05-14 W.L. Gore & Associates, Inc. PROCEDE D'AMELIORATION DE LA FIABILITE DE SUPPORTS DE CIRCUITS MINCES EN AUGMENTANT LA Tg DU SUPPORT
EP1952820A3 (fr) * 1998-03-06 2012-06-20 Chugai Seiyaku Kabushiki Kaisha Formules G-CSF sans protéine
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US20020198150A1 (en) * 2001-06-07 2002-12-26 Ayelet Chajut Methods of using colony stimulating factors in the treatment of tissue damage and ischemia
EP2426139B1 (fr) 2002-08-27 2014-10-01 Biokine Therapeutics Ltd. Antagoniste CXCR4 et son utilisation
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
WO2009100255A2 (fr) 2008-02-08 2009-08-13 Ambrx, Inc. Polypeptides leptine modifiés et leurs utilisations
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
WO2008075370A2 (fr) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. Analogues peptidiques de t-140 présentant une activité superagoniste par rapport à cxcr4 destinés à une cancérothérapie
US10138283B2 (en) 2008-07-23 2018-11-27 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
EP2396023A2 (fr) 2009-02-11 2011-12-21 Yeda Research and Development Co. Ltd. Peptides courts dérivés de bêta-défensine
US9427456B2 (en) 2009-06-14 2016-08-30 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
EP2841084B1 (fr) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
CA2986705A1 (fr) 2015-07-16 2017-01-19 Biokine Therapeutics Ltd. Inhibiteur de cxcr4 et antagoniste de proteine disulfure isomerase a utiliser dans le traitement du cancer
JP6676182B2 (ja) 2016-02-23 2020-04-08 バイオラインアールエックス・リミテッドＢｉｏＬｉｎｅＲｘ Ｌｔｄ． 急性骨髄性白血病の治療方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
DE68911061T2 (de) 1994-03-24
IL91423A (en) 1995-06-29
IL91423A0 (en) 1990-04-29
US5202117A (en) 1993-04-13
AU625914B2 (en) 1992-07-16
KR950003492B1 (ko) 1995-04-13
EP0355811B1 (fr) 1993-12-01
DE68911061D1 (de) 1994-01-13
AU4014789A (en) 1990-03-01
EP0355811A3 (fr) 1991-03-20
ATE97813T1 (de) 1993-12-15
EP0355811A2 (fr) 1990-02-28
CA1339071C (fr) 1997-07-29
KR900002800A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
IL91423A0 (en) Thrombus control agent
AU3275689A (en) Process for stabilizing human albumin solutions and the solution obtained
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
HUT60436A (en) Process for producing pharmaceutical composition active mainly on thrombo-embolitic conditions of circulatory system and heart
ZA95679B (en) Products containing G-CSF and TNF binding protein
GR3025134T3 (en) Process for preparing a concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
ZA907040B (en) Fatty acid therapy
HK46196A (en) Treatment of leukocyte dysfunction with gm-csf
RU95113499A (ru) Способ повышения мочеотделения у человека, способ снижения уровней холестерина и липопротеинов низкой плотности, применение (+) доксазозина
JPS6483020A (en) Medicinal composition for preventing or treating aids
ZA891366B (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmias
GR3032224T3 (en) Therapeutic agent for threatened abortion.
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
EP0212310A3 (en) Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia
GR3000751T3 (en) Tpa-containing medical composition and use thereof
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
EP0340933A3 (fr) Formules contenant de l'héparine
ZA913920B (en) Therapeutic compound
EP0312132A3 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
CA2186752A1 (fr) Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps
IL125789A (en) USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
IT8500516V0 (it) Attrezzo da ginnastica-verticallinea-per prevenire,curare, migliorare la salute e l'aspetto del corpo umano